These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 6975377)

  • 1. Raynaud's phenomenon and initially seronegative mixed connective tissue disease.
    Ellman MH; Pachman L; Medof ME
    J Rheumatol; 1981; 8(4):632-4. PubMed ID: 6975377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinuclear antibodies in scleroderma, mixed connective tissue disease and "primary" Raynaud's phenomenon.
    Cruz M; Mejia G; Lavalle C; Cortes JJ; Reyes PA
    Clin Rheumatol; 1988 Mar; 7(1):80-6. PubMed ID: 3261675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ; Mogavero H; Reichlin M
    J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raynaud's phenomenon in mixed connective tissue disease.
    Grader-Beck T; Wigley FM
    Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease].
    Yokota S; Kuriyama T; Takahashi Y; Mori M; Shike H; Ibe M; Mitsuda T; Aihara Y
    Ryumachi; 1994 Dec; 34(6):955-60. PubMed ID: 7863385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis?
    Kallenberg CG; Wouda AA; The TH
    Neth J Med; 1984; 27(9):322-6. PubMed ID: 6334812
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic workup for mixed connective tissue disease in childhood.
    Swart JF; Wulffraat NM
    Isr Med Assoc J; 2008; 10(8-9):650-2. PubMed ID: 18847172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mixed connective tissue disease in childhood].
    Yokota S
    Ryumachi; 1994 Dec; 34(6):947-54. PubMed ID: 7863384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolutive aspects of Sharp's mixed connective tissue disease. 23 cases (author's transl)].
    Naveau B; Dryll A; Peltier AP; Kahn MF; Ryckewaert A
    Nouv Presse Med; 1981 Sep; 10(33):2731-3. PubMed ID: 6974852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed connective tissue disease - a subset with sequential clinical and laboratory features.
    Grant KD; Adams LE; Hess EV
    J Rheumatol; 1981; 8(4):587-98. PubMed ID: 6975376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of undifferentiated connective tissue disease: is it a distinct clinical entity?
    Mosca M; Tani C; Bombardieri S
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):328-32. PubMed ID: 18414458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Raynaud's phenomenon and anticentromere antibodies].
    Marquet Palomer R; Vilardell Tarrés M; Ordi Ros J
    Med Clin (Barc); 1987 Nov; 89(17):721-4. PubMed ID: 3501051
    [No Abstract]   [Full Text] [Related]  

  • 15. An unusual cause of abdominal fullness in a patient with Raynaud's phenomenon. Mixed connective tissue disease.
    Hokama A; Kishimoto K; Nakamoto M; Kinjo N; Kinjo F; Fujita J
    Gut; 2008 Jun; 57(6):733, 820. PubMed ID: 18477675
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary hypertension not a major feature of early mixed connective tissue disease: a prospective clinicoserological study.
    Haroon N; Nisha RS; Chandran V; Bharadwaj A
    J Postgrad Med; 2005; 51(2):104-7, discussion 107-8. PubMed ID: 16006700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed connective tissue disease.
    Minkin W; Rabhan N
    Arch Dermatol; 1976 Nov; 112(11):1535-8. PubMed ID: 1086651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in a child with mixed connective tissue disease.
    Rosenberg AM; Petty RE; Cumming GR; Koehler BE
    J Rheumatol; 1979; 6(6):700-4. PubMed ID: 529255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.